Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
Royalty Pharma, Teva Partner on $500M Deal to Develop Vitiligo Treatment
Royalty Pharma will provide up to $500 million to accelerate Teva's development of TEV-408, an anti-IL-15 antibody candidate for vitiligo and celiac disease, a…
HighThree Health Warnings: Heart Failure in Younger Adults, a Rising Breast Cancer Trend, and an Intense Tick Season
A roundup of three health alerts: a survey shows few people would seek urgent cardiac care for heart failure symptoms, breast cancer rates rise among young Asi…
MediumNew Antibody Shows Promise in Halting Aggressive Prostate Cancer Spread
Scientists developed a fully human antibody that halted aggressive prostate cancer growth and metastasis in preclinical studies, potentially offering a safer t…
HighRare Bundibugyo Ebola strain kills 118 in DRC and Uganda outbreak
A deadly outbreak of the Bundibugyo Ebola strain has killed 118 people across the Democratic Republic of Congo and Uganda, with 300 suspected cases and no avai…
HighSemaglutide slows dementia-linked blood protein signature in older adults
A post hoc analysis of 2,970 older SELECT trial participants found semaglutide slowed worsening of a 25-protein blood signature predicting dementia risk, with…
MediumGLP-1 Drug Surge Reshapes Obesity Treatment as Bariatric Surgery Declines
GLP-1 prescription use has quadrupled since 2021, coinciding with a sharp decline in bariatric surgery rates across the US as patients opt for pharmaceutical a…
HighRetatrutida achieves 30% weight loss in landmark obesity study
Eli Lilly's experimental drug retatrutida demonstrated 30% average weight loss over 104 weeks in a major clinical trial presented at the American Diabetes Asso…
HighEbola's Hidden Crisis: Why Children Are Excluded From Life-Saving Treatments
Children under 12 face disproportionately high Ebola mortality in DRC outbreak due to exclusion from clinical trials and lack of pediatric-formulated treatment…
HighBird Flu Pandemic Fears, Weight-Loss Drug Price Pressure Dominate Health News
Health authorities warn of slow-moving bird flu pandemic risks while drugmakers face legal challenges over Zantac and COVID vaccines. Meanwhile, weight-loss dr…
HighNigeria confirms Ebola case in Abuja as outbreak spreads across East Africa
Nigeria confirmed an Ebola case in Abuja in a female patient who traveled from Uganda, marking the virus's spread to a fourth African country amid an ongoing o…
HighMarengo's Bispecific Antibody Shrinks Tumors Across Eight Cancer Types in Phase 2 Trial
Marengo Therapeutics reported Phase 2 STARt-001 results at ESMO 2026 showing single-agent activity of bispecific dual T-cell agonist invikafusp alfa across TMB…
MediumBrigham and Women's Launches First Human Trial of Nasal Alzheimer's Vaccine
Brigham and Women's Hospital begins the first human clinical trial of a nasal vaccine for Alzheimer's disease, testing safety and immune response in 16 partici…
HighJapan's Nipah Vaccine Enters First Human Trials in April
Japanese researchers will begin Phase 1 human trials of a novel Nipah vaccine in Belgium this April, offering hope against a virus with 40-75% fatality rate fo…
HighWHO declares global health emergency over rare Ebola variant in DRC
WHO declares Ebola outbreak in DRC and Uganda a public health emergency after 300+ suspected cases and 88 deaths, caused by rare Bundibugyo virus variant with…
HighFirst Bourbon Virus Case Confirmed in New York; Rare Tick-Borne Illness Has No Treatment
New York confirms its first case of Bourbon Virus, a rare tick-borne illness with no vaccine or cure that can be potentially fatal. Health officials warn cases…
HighPfizer Reshapes Oncology Strategy Through SCRI Partnership and VEPPANU Licensing
Pfizer announces partnerships with Sarah Cannon Research Institute and Rigel Pharmaceuticals to advance oncology development, reflecting a shift toward externa…
HighCelebrity Endorsements Drive Cancer Patients to Unproven Ivermectin Treatment
Ivermectin prescriptions doubled after Mel Gibson promoted the antiparasitic drug as a cancer treatment on Joe Rogan's podcast, despite lacking clinical eviden…
HighFDA Approves Vera Therapeutics' Trutakna for IgA Nephropathy, Challenging Novartis and Otsuka
The FDA has approved Vera Therapeutics' Trutakna, a dual-target treatment for IgA nephropathy (IgAN), positioning the company to compete with Novartis and Otsu…
HighUK launches £20m organoid project to replace animal drug testing with human tissue models
UK scientists will grow miniature human organs from patient cells to test drugs more accurately and reduce animal testing. A £20m Cambridge hub will create sta…
HighResearchers identify MEK inhibitors as potential treatment for myelodysplastic syndrome
Mount Sinai and UC San Diego researchers identified how RNA splicing mutations drive myelodysplastic syndrome, revealing that existing FDA-approved MEK inhibit…
HighOral GLP-1 drugs emerge as next frontier in weight loss treatment race
Pharmaceutical companies are advancing oral GLP-1 medications as alternatives to injectable weight loss drugs, with new formulations delivering up to 12% weigh…
HighAlzheimer's Patient Shows Brain Plaque Clearance After 18 Months of Treatment
An Alzheimer's patient in Pompano Beach experienced clearance of brain plaques after 18 months of treatment, with real-world drug performance matching clinical…
MediumSemaglutide Dosing Errors Flood Poison Control Centers Post-FDA Approval
Poison control calls involving semaglutide surged after FDA approval for weight management, with research showing most incidents stem from accidental dosing mi…
HighKenya's Ebola Outbreak: Nine Cases Confirmed, Containment Efforts Underway
Kenya confirms nine Ebola cases linked to a traveler from DR Congo, prompting international travel warnings and regional alert. Authorities assert containment…
HighResearchers identify MEK inhibitors as potential treatment for myelodysplastic syndrome
Mount Sinai and UC San Diego researchers discovered that RNA splicing mutations in myelodysplastic syndrome can be targeted with FDA-approved MEK inhibitors, p…
HighEarly amyloid-removal drug cuts Alzheimer's dementia risk in half for genetic carriers
An experimental anti-amyloid drug reduced Alzheimer's dementia risk from near-certain to 50% in people with genetic mutations causing early-onset disease, offe…
HighALS Drug Edaravone Shows Promise Against Glioblastoma Stem Cells
Researchers found that edaravone, an FDA-approved ALS drug, effectively suppresses glioblastoma stem cells when combined with radiation therapy, offering poten…
HighFrance confirms first Ebola case linked to DRC outbreak
France confirmed its first domestic Ebola case in a doctor returning from humanitarian work in the DRC. Health authorities isolated five flight contacts while…
HighEMA Recommends Emergency Use of Pfizer's Paxlovid Covid-19 Pill
The European Medicines Agency recommended emergency use of Pfizer's Paxlovid antiviral pill for COVID-19 treatment in high-risk adults, citing data showing sig…
HighNHS rolls out faster cancer drug injection, cutting hospital visits from hours to minutes
NHS patients will receive Keytruda cancer treatment as a quick injection instead of hour-long infusions, potentially freeing hospital resources and improving p…
HighMount Sinai Develops ML Model to Predict Dialysis Need, Mortality in COVID-19 Patients
Mount Sinai researchers developed a machine learning model using XGBoost to predict which hospitalized COVID-19 patients will require dialysis or face critical…
HighUK launches major trial testing semaglutide for alcohol addiction and obesity
A £2.7M UK trial will test whether semaglutide, a weight-loss drug, can simultaneously reduce alcohol cravings and improve liver health in patients with alcoho…
HighDR Congo Ebola death toll climbs to 131 as outbreak spreads across provinces
The Democratic Republic of Congo's Ebola outbreak has claimed an estimated 131 deaths from 513 suspected cases, with the Bundibugyo strain spreading across nor…
HighCongo's Ebola outbreak nears 300 cases as recovered health workers offer hope
Congo confirms 282 Ebola cases concentrated in eastern Ituri province, with 43 deaths reported. Recovery stories from medical workers offer hope as internation…
HighLarge study links semaglutide use to 49% lower COVID-19 mortality risk
A 10.1 million-person observational study found semaglutide use associated with 49% lower COVID-19 mortality, corroborating earlier trial results but requiring…
HighModerna launches Phase 1 trial of Ebola vaccine as DRC outbreak death toll exceeds 1,700
Moderna has initiated Phase 1 clinical trials of an mRNA vaccine targeting the Bundibugyo Ebola strain driving a major outbreak in the Democratic Republic of C…
HighPfizer's Updated COVID Booster Shows Promise Against Omicron Variants
Pfizer and BioNTech released first human trial data showing updated bivalent COVID boosters provide stronger antibody response against BA.4 and BA.5 variants c…
HighCongo's Ebola outbreak death toll surges to 930 amid security challenges
Congo's Ebola outbreak has killed at least 930 people out of 2,344 confirmed cases, with 37 deaths in a single 24-hour period. The fastest-growing Ebola outbre…
HighAntidepressant debate intensifies as patients seek balanced information
Multiple perspectives emerge on antidepressant efficacy and patient information, with critics advocating for holistic alternatives while medical professionals…
MediumAustria confirms suspected Ebola case as virus spreads from Uganda outbreak
Austria reports a suspected Ebola case in a patient returning from Uganda, where the Bundibugyo strain has killed 220 people. Initial tests were negative but c…
HighTOLREMO's TT125-802 Wins Dual FDA Fast Track Status for Drug-Resistant Lung Cancer
TOLREMO therapeutics received two FDA Fast Track designations for TT125-802, a novel cancer drug targeting drug-resistant EGFR and KRAS-G12C mutated non-small…
HighNCCN Launches Tailored Cancer Treatment Guidelines for Philippines
The National Comprehensive Cancer Network is collaborating with Philippine medical organizations to develop localized cancer treatment guidelines covering 11 d…
HighStudy reveals type 2 diabetes in lean Africans requires different treatment approach
Research reveals type 2 diabetes in lean Africans stems from insulin deficiency, not resistance, yet they receive the same medications as overweight patients,…
HighDIY Weight-Loss Drug Users Turn to Microdosing as Demand Soars
Patients are self-administering lower doses of popular weight-loss drugs like Ozempic and Wegovy to save money and reduce side effects, but medical experts war…
HighCancer Patients Turn to Unproven Ivermectin After Celebrity Podcast Endorsement
Cancer patients are increasingly seeking ivermectin, an antiparasitic drug, after actor Mel Gibson endorsed it as a cancer treatment on Joe Rogan's podcast, de…
HighBerlin admits American Ebola patient as outbreak kills 131 in Congo
An American missionary doctor infected with Ebola in the Democratic Republic of Congo was transferred to Berlin's Charité Hospital for treatment, with six addi…
HighBlood Test Shows Promise for Detecting Dementia 15 Years Early
Scientists have identified blood biomarkers that can predict dementia up to 15 years before clinical diagnosis, offering potential for early intervention and t…
HighIntegrated disease testing could cut costs, improve TB outcomes in Philippines
A Filipino TB specialist proposes integrated multi-disease testing to reduce patient burden and improve treatment outcomes, addressing diagnostic gaps that con…
HighGene fusion patterns predict aggressive solitary fibrous tumor outcomes
Research identifies specific genetic fusion variants in solitary fibrous tumors that correlate with metastasis risk and disease aggressiveness, potentially ena…
MediumDrug-resistant Shigella outbreak spreads across Ohio amid sexual transmission concerns
A sexually transmitted Shigella outbreak is spreading across Ohio, including Stark County, with hundreds sickened by the increasingly antibiotic-resistant bact…
High